AURQF yields 133333.33% · JNJ yields 2.13%● Live data
📍 AURQF pulled ahead of the other in Year 1
Combined, AURQF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AURQF + JNJ for your $10,000?
Aurelius Minerals Inc., an exploration stage company, engages in acquisition, exploration, and evaluation of mineral properties in Canada. The company explores for gold. It holds a 100% interest in the Lipton property with 57 claims covering an area of approximately 12,425 hectares; and the Mikwam property with 69 cell claims covering an area of approximately 968 hectares located within the northern Abitibi Gold Belt in Ontario. The company also holds interests in the Aureus gold properties, including Aureus West and East with 104 mineral claims covering an area of approximately 1,684 hectares in Abitibi Greenstone Belt in Ontario; the Tangier gold project; and the Forest Hill Gold project comprise 115 contiguous mineral exploration claims in four exploration licenses with an aggregate area of 1,840 hectares. The company was formerly known as Galena International Resources Ltd. and changed its name to Aurelius Minerals Inc. in January 2017. Aurelius Minerals Inc. was incorporated in 2007 and is based in Toronto, Canada.
Full AURQF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.